The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Open accessAbstract
BACKGROUND: Several short antimicrobial peptides that are rich in tryptophan and arginine residues were designed with a series of simple modifications such as end capping and cyclization. The two sets of hexapeptides are based on the Trp- and Arg-rich primary sequences from the "antimicrobial centre" of bovine lactoferricin as well as an antimicrobial sequence obtained through the screening of a hexapeptide combinatorial library. METHODOLOGY/PRINCIPAL FINDINGS: HPLC, mass spectrometry and antimicrobial assays were carried out to explore the consequences of the modifications on the serum stability and microbicidal activity of the peptides. The results show that C-terminal amidation increases the antimicrobial activity but that it makes little difference to its proteolytic degradation in human serum. On the other hand, N-terminal acetylation decreases the peptide activities but significantly increases their protease resistance. Peptide cyclization of the hexameric peptides was found to be highly effective for both serum stability and antimicrobial activity. However the two cyclization strategies employed have different effects, with disulfide cyclization resulting in more active peptides while backbone cyclization results in more proteolytically stable peptides. However, the benefit of backbone cyclization did not extend to longer 11-mer peptides derived from the same region of lactoferricin. Mass spectrometry data support the serum stability assay results and allowed us to determine preferred proteolysis sites in the peptides. Furthermore, isothermal titration calorimetry experiments showed that the peptides all had weak interactions with albumin, the most abundant protein in human serum. CONCLUSIONS/SIGNIFICANCE: Taken together, the results provide insight into the behavior of the peptides in human serum and will therefore aid in advancing antimicrobial peptide design towards systemic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Calculation of protein extinction coefficients from amino acid sequence data
Gill, S. C., & von Hippel, P. H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90602-7 · Cited by 5,283
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
Self-citationPark, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Magainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Gifford, J. L., Hunter, H. N., & Vogel, H. J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5373-z · Cited by 528
Self-citationHigh-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Cited by
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Self-citationKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics
Góngora-Benítez, M., Tulla-Puche, J., & Albericio, F. (2014) · Chemical Reviews · doi:10.1021/cr400031z · Cited by 655
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Metadata
- Authors
- Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-09-10
- Volume
- 5
- Issue
- 9
- Pages
- e12684
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2038283518
- Cited by
- 333
- References
- 47
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs. https://app.cochat.ai/papers/10.1371/journal.pone.0012684
- The paper
- Nguyen, L. T., Chau, J. K., Perry, N. A., de Boer, L., Zaat, S. A. J., & Vogel, H. J. (2010). Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs. PLoS ONE. https://doi.org/10.1371/journal.pone.0012684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.